SlideShare a Scribd company logo
1 of 34
Urinary Tract Infection
In Children
Dr. Rajesh K.C.
Resident, Pediatrics
Definition:-
• Invasion & multiplication of micro-organisms in the urinary system.
• Important cause of morbidity in children.
• Can cause renal damage if recurrent.
• Is often is associated with Vesico-ureteric reflux.
Incidence:-
• UTI occur in 1% of boys and 1-3% of girls.
• Newborn : M=F
Hematogenous spread
Cong. anomalies in males
• During the 1st yr of life,
• M:F is 2.8-5.4 : 1.
• More in uncircumscribed boys.
• Beyond 1 yr : F>M (10 : 1).
Ascending infection
Classification:-
A. On the basis of underlying defect:-
• Simple
• Complicated
B. On the basis of region involved:-
• Upper UTI - Pyelonephritis
• Lower UTI –Cystitis
C. Based on symptoms:-
• Symptomatic UTI
• Asymptomatic UTI
Causes of UTI
Causes:-
A. Bacteria:-
• E.coli (75 -90%)
• Proteus
• Klebsiella
• Staph. saprophyticus
• Pseudomonas
• Group B streptococcus
• H. Influenza
*Proteus and Pseudomonas infections occur following obstruction or instrumentation.
Causes:-
B. Virus:-
• Ebstein Barr
• Adeno virus
• HSV-2
C) Fungus:-
• Candida- immunocompromised children.
- after prolonged antimicrobial therapy
D) Parasites
Risk Factors
1.Host Factors:-
a) Stasis -Infrequent & Incomplete voiding
Constipation
Obstruction to flow-PUV, PUJ obstruction, stones
Ureterocele
Neurogenic bladder
b) Instrumentation
c) Malnutrition
Risk Factors
d) No circumcision
e) Length of urethra
f) Bubble bath
g) Toilet training
h) Pinworms
i) Indwelling catheter
j) Sexual activity
k) Pregnancy
2. Agent – organisms causing UTI.
Risk Factors
According to the 2011 AAP Guidelines for children 2-24 mon
• Risk factors for girls :-
• white race,
• age younger than 12 mon,
• temperature >39°C (102.2°F),
• fever for longer than 2 days, and
• absence of another source of infection.
• Risk factors for boys:-
• non-black race,
• temperature >39°C (102.2°F),
• fever for longer than 24 hrs, and
• absence of another source of infection.
Clinical Features
• Depend upon age and severity.
0-1 year:-
• Fever/Hypothermia
• Vomiting
• Diarrhea
• Sepsis
• Irritability
• Lethargy
• Jaundice
• Malodorous urine
• Poor weight gain
1-5 years:-
• Abdominal pain
• Vomiting
• Diarrhea
• Constipation
• Abnormal voiding
• Malodorous Urine
• Fever/febrile convulsion
• Failure to thrive
>5 years:-
• Dysuria
• Frequency
• Urgency
• Abdominal discomfort
• Fever
• Malodorous urine
Physical Examinations
• Temperature
• Pallor
• Anthropometry
• Blood Pressure
• Tenderness-Lower abdomen
Renal angle
• Renal mass
• Palpable bladder
Physical Examinations
• Fecal mass
• Signs of vulvitis
• Spine
• Lower limb reflexes
• Associated with UTI -Prune belly syndrome
Anorectal anomalies
Management
Investigations:-
1. Urine R/M/E
2. Urine C/S
• Methods of urine collection:-
1. Clean catch or midstream sample- toilet trained
2. Suprapubic aspiration – 2-24 mon
3. Catheter specimen – severely ill
4. Urinary bag sample – alternative.
Routine Examination of Urine
• Color- Hazy
• Smell- malodorous
• Pus cell >10/HPF (F) , >5 /HPF (M)
• RBC >5 /HPF
• RBC and WBC casts +
• Albumin – Trace to +
Urine C/S :-
1. >50,000 colonies of a single pathogen in suprapubic or catheter sample.
2. 10,000 colonies in the symptomatic child.
3. If the urinalysis result is positive, the patient is symptomatic, single
organism with a colony count >100,000.
4. If any of these criteria are not met, confirmation of infection with a
catheterized sample is recommended.
Imaging studies
1.Radiological – MCU
IVP
X-ray KUB
2. Nuclear- USG
DMSA scan - dimercaptosuccinic acid.
DTPA scan - diethylene triamine pentacetate.
MAG 3 scan- mercapto acetyl tri glycine.
Renal scans
• DMSA renal scan – anatomy of kidney (Scarring)
• DTPA renal scan – Excretory function ,filtration function of kidney
• MAG 3 with lasix renal scan – Sensitive quantitative information regarding kidney
function and drainage , assesses the degree of blockage
Principles of management
1. Treatment of acute infection
2. Prevention of further infection
3. Adequate investigation
4. Arrangement of further treatment
5. Follow up
Choice & route of Treatment
Usual indications for hospitalization for parenteral abx:-
• Age <1 months
• Clinical urosepsis or potential bacteremia
• Immunocompromised patient
• Complicated infection
• Vomiting or inability to tolerate oral medication
• Dehydrated
• Lack of adequate outpatient follow-up
• Failure to respond to outpatient therapy
• Most infants older than one months with simple UTI can be safely managed as outpatients if
follow-up is possible.
• Empiric antimicrobial therapy be initiated while awaiting culture results.
• If symptoms are mild and diagnosis is doubtful treatment can be awaited till c/s reports.
• The ultimate choice of antimicrobial therapy is based upon the sensitivities of the urine
culture isolate.
• The duration of treatment:- Complicated UTI : 10-14days.
Simple UTI : 7-10 days.
• Asymptomatic bacteriuria does not require treatment except in pregnant.
• Usually after 48-72 hrs, symptoms abate and oral intake improves and therapy is switched
to an oral antibiotics.
• Urine cultures should be repeated after 72 hours of therapy if the uropathogen is not
susceptible to the antibiotic that is being used for treatment or if susceptibility testing is
not performed.
• Asymptomatic bacteriuria do not require treatment.
• Routine alkalization of the urine is not necessary.
• Parenteral antibiotics
• Ceftriaxone 50-75mg/kg/day
• Cefotaxime 100mg/kg/day
• Inj Ampicillin (100mg/kg/day) + Inj. Gentamycin (3-5mg/kg/day)
• Oral antibiotics
• Cefixime 8-10mg/kg/day
• Coamoxiclav 30-35mg/kg/day
• Ciprofloxacin 10-20 mg/kg/day
• Ofloxacin 15-20 mg/kg/day
• Cephalexin 50-70mg/kg/day
• Nitrofurantoin -1mg/kg/d
• Co-trimoxazole-2mg/kg/d
Prevention
1. General measures:-
• Fluid intake
• Complete and periodic voiding
• Vioding at bed time
• Perineal hyiene
• Treatment of worms
• Prevention of constipation
• Avoid catheterization
Prevention
• Early treatment of congenital anomalies
• Circumcision
2. Low dose chemoprophylaxis
• UTI until radiological evaluation is complete.
• Recurrent UTI (3 or more in a year).
• VUR grade I- III
• Post operative-PUJ,VUR grade IV & V, PUV
• Chronic cystitis
• Neurogenic bladder
Prevention
Commonly used drugs for prophylaxis:-
• Co-trimoxazole-2mg/kg/d
• Nalidixic acid-12.5mg/Kg/d
• Nitrofurantoin -1mg/kg/d
Follow up
1. Clinical-
• During the year following infection
• 1 year after starting prophylaxis
• height, Blood pressure –recorded
2. Urine C/S-
• 3 monthly-infancy
• Fever & symptoms –older children
3. RFT
4. Imaging –when needed
Thank You!!

More Related Content

What's hot

Uti -for_non-urologists-uncomplicated and complicated
Uti  -for_non-urologists-uncomplicated and complicatedUti  -for_non-urologists-uncomplicated and complicated
Uti -for_non-urologists-uncomplicated and complicated
maiim
 
Cystitis --period 1
Cystitis --period 1Cystitis --period 1
Cystitis --period 1
romswinckel
 
Urinary Tract Infection In Children
Urinary Tract Infection In ChildrenUrinary Tract Infection In Children
Urinary Tract Infection In Children
LAB IDEA
 

What's hot (18)

urinary tract infection;pediatric
urinary tract infection;pediatricurinary tract infection;pediatric
urinary tract infection;pediatric
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
 
Evidence update in uti
Evidence update in utiEvidence update in uti
Evidence update in uti
 
Drug therapy in uti in children
Drug  therapy in  uti  in  childrenDrug  therapy in  uti  in  children
Drug therapy in uti in children
 
Urinary Tract Infection in Children
Urinary Tract Infection in ChildrenUrinary Tract Infection in Children
Urinary Tract Infection in Children
 
Urinary tract infection in children
Urinary tract infection in childrenUrinary tract infection in children
Urinary tract infection in children
 
Case study urinary tract infection
Case study urinary tract infectionCase study urinary tract infection
Case study urinary tract infection
 
UTI in children Dr GRK
UTI in children Dr GRKUTI in children Dr GRK
UTI in children Dr GRK
 
Newa sandesh
Newa sandeshNewa sandesh
Newa sandesh
 
Uti -for_non-urologists-uncomplicated and complicated
Uti  -for_non-urologists-uncomplicated and complicatedUti  -for_non-urologists-uncomplicated and complicated
Uti -for_non-urologists-uncomplicated and complicated
 
Prevention of UTI references
Prevention of UTI referencesPrevention of UTI references
Prevention of UTI references
 
Management of uti
Management of utiManagement of uti
Management of uti
 
Urinary tract infections (UTI) & Renal vascular diseases
Urinary tract infections (UTI) & Renal vascular diseasesUrinary tract infections (UTI) & Renal vascular diseases
Urinary tract infections (UTI) & Renal vascular diseases
 
UTI Case Presentation
UTI Case PresentationUTI Case Presentation
UTI Case Presentation
 
Cystitis --period 1
Cystitis --period 1Cystitis --period 1
Cystitis --period 1
 
Urinary tract-infections-children
Urinary tract-infections-childrenUrinary tract-infections-children
Urinary tract-infections-children
 
Urinary Tract Infection In Children
Urinary Tract Infection In ChildrenUrinary Tract Infection In Children
Urinary Tract Infection In Children
 
Urinalysis
Urinalysis Urinalysis
Urinalysis
 

Similar to Urinary Tract Infection

Similar to Urinary Tract Infection (20)

Urinary Tract Infections
Urinary Tract InfectionsUrinary Tract Infections
Urinary Tract Infections
 
UTI in children
UTI in childrenUTI in children
UTI in children
 
Pediatric Urinary Tract infections
Pediatric Urinary Tract infectionsPediatric Urinary Tract infections
Pediatric Urinary Tract infections
 
URINARY TRACT INFECTION URINARY TRACT INFECTION
URINARY TRACT INFECTION URINARY TRACT INFECTIONURINARY TRACT INFECTION URINARY TRACT INFECTION
URINARY TRACT INFECTION URINARY TRACT INFECTION
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
 
UTI.pptx
UTI.pptxUTI.pptx
UTI.pptx
 
Urinarytractinfections
UrinarytractinfectionsUrinarytractinfections
Urinarytractinfections
 
Uti a surgeons perspective
Uti a surgeons perspectiveUti a surgeons perspective
Uti a surgeons perspective
 
Urinary Tract Infections UTI. Diagnosis1
Urinary Tract Infections UTI. Diagnosis1Urinary Tract Infections UTI. Diagnosis1
Urinary Tract Infections UTI. Diagnosis1
 
Liver Abscess by Dr Mudassir Baig PIMS.pptx
Liver Abscess by Dr Mudassir Baig PIMS.pptxLiver Abscess by Dr Mudassir Baig PIMS.pptx
Liver Abscess by Dr Mudassir Baig PIMS.pptx
 
14. UTIs.ppt
14. UTIs.ppt14. UTIs.ppt
14. UTIs.ppt
 
Typhoid fever overview
Typhoid fever overview Typhoid fever overview
Typhoid fever overview
 
uti-160315210213.pptxDDDDDDDDDDDDDDDDDDDD
uti-160315210213.pptxDDDDDDDDDDDDDDDDDDDDuti-160315210213.pptxDDDDDDDDDDDDDDDDDDDD
uti-160315210213.pptxDDDDDDDDDDDDDDDDDDDD
 
A Clinical Approch Towards Certain Urological Maladies
A Clinical Approch Towards Certain Urological MaladiesA Clinical Approch Towards Certain Urological Maladies
A Clinical Approch Towards Certain Urological Maladies
 
Complication peritoneal dailysis traning
Complication peritoneal dailysis traningComplication peritoneal dailysis traning
Complication peritoneal dailysis traning
 
URINARY TRACT INFECTION
URINARY TRACT INFECTIONURINARY TRACT INFECTION
URINARY TRACT INFECTION
 
Urinary tracts infections in pediatrics (UTI)
Urinary tracts infections in pediatrics (UTI)Urinary tracts infections in pediatrics (UTI)
Urinary tracts infections in pediatrics (UTI)
 
UTI in children.common infection in neonates
UTI in children.common infection in neonatesUTI in children.common infection in neonates
UTI in children.common infection in neonates
 
ASYMTOMATIC BACTERIURA & UTI IN PREGNANCY.ppt
ASYMTOMATIC BACTERIURA  & UTI IN PREGNANCY.pptASYMTOMATIC BACTERIURA  & UTI IN PREGNANCY.ppt
ASYMTOMATIC BACTERIURA & UTI IN PREGNANCY.ppt
 
Diverticular disease of the colon hegazy
Diverticular disease of the colon hegazyDiverticular disease of the colon hegazy
Diverticular disease of the colon hegazy
 

Recently uploaded

SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
Peter Brusilovsky
 
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
EADTU
 
Orientation Canvas Course Presentation.pdf
Orientation Canvas Course Presentation.pdfOrientation Canvas Course Presentation.pdf
Orientation Canvas Course Presentation.pdf
Elizabeth Walsh
 

Recently uploaded (20)

Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
 
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptxMichaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf arts
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use Cases
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
VAMOS CUIDAR DO NOSSO PLANETA! .
VAMOS CUIDAR DO NOSSO PLANETA!                    .VAMOS CUIDAR DO NOSSO PLANETA!                    .
VAMOS CUIDAR DO NOSSO PLANETA! .
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 
Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Observing-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptxObserving-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptx
 
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
 
Orientation Canvas Course Presentation.pdf
Orientation Canvas Course Presentation.pdfOrientation Canvas Course Presentation.pdf
Orientation Canvas Course Presentation.pdf
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdfDiuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
 

Urinary Tract Infection

  • 1. Urinary Tract Infection In Children Dr. Rajesh K.C. Resident, Pediatrics
  • 2.
  • 3. Definition:- • Invasion & multiplication of micro-organisms in the urinary system. • Important cause of morbidity in children. • Can cause renal damage if recurrent. • Is often is associated with Vesico-ureteric reflux.
  • 4. Incidence:- • UTI occur in 1% of boys and 1-3% of girls. • Newborn : M=F Hematogenous spread Cong. anomalies in males • During the 1st yr of life, • M:F is 2.8-5.4 : 1. • More in uncircumscribed boys. • Beyond 1 yr : F>M (10 : 1). Ascending infection
  • 5. Classification:- A. On the basis of underlying defect:- • Simple • Complicated B. On the basis of region involved:- • Upper UTI - Pyelonephritis • Lower UTI –Cystitis C. Based on symptoms:- • Symptomatic UTI • Asymptomatic UTI
  • 7. Causes:- A. Bacteria:- • E.coli (75 -90%) • Proteus • Klebsiella • Staph. saprophyticus • Pseudomonas • Group B streptococcus • H. Influenza *Proteus and Pseudomonas infections occur following obstruction or instrumentation.
  • 8. Causes:- B. Virus:- • Ebstein Barr • Adeno virus • HSV-2 C) Fungus:- • Candida- immunocompromised children. - after prolonged antimicrobial therapy D) Parasites
  • 9. Risk Factors 1.Host Factors:- a) Stasis -Infrequent & Incomplete voiding Constipation Obstruction to flow-PUV, PUJ obstruction, stones Ureterocele Neurogenic bladder b) Instrumentation c) Malnutrition
  • 10. Risk Factors d) No circumcision e) Length of urethra f) Bubble bath g) Toilet training h) Pinworms i) Indwelling catheter j) Sexual activity k) Pregnancy 2. Agent – organisms causing UTI.
  • 11. Risk Factors According to the 2011 AAP Guidelines for children 2-24 mon • Risk factors for girls :- • white race, • age younger than 12 mon, • temperature >39°C (102.2°F), • fever for longer than 2 days, and • absence of another source of infection. • Risk factors for boys:- • non-black race, • temperature >39°C (102.2°F), • fever for longer than 24 hrs, and • absence of another source of infection.
  • 12. Clinical Features • Depend upon age and severity.
  • 13. 0-1 year:- • Fever/Hypothermia • Vomiting • Diarrhea • Sepsis • Irritability • Lethargy • Jaundice • Malodorous urine • Poor weight gain
  • 14. 1-5 years:- • Abdominal pain • Vomiting • Diarrhea • Constipation • Abnormal voiding • Malodorous Urine • Fever/febrile convulsion • Failure to thrive
  • 15. >5 years:- • Dysuria • Frequency • Urgency • Abdominal discomfort • Fever • Malodorous urine
  • 16. Physical Examinations • Temperature • Pallor • Anthropometry • Blood Pressure • Tenderness-Lower abdomen Renal angle • Renal mass • Palpable bladder
  • 17. Physical Examinations • Fecal mass • Signs of vulvitis • Spine • Lower limb reflexes • Associated with UTI -Prune belly syndrome Anorectal anomalies
  • 19. Investigations:- 1. Urine R/M/E 2. Urine C/S • Methods of urine collection:- 1. Clean catch or midstream sample- toilet trained 2. Suprapubic aspiration – 2-24 mon 3. Catheter specimen – severely ill 4. Urinary bag sample – alternative.
  • 20. Routine Examination of Urine • Color- Hazy • Smell- malodorous • Pus cell >10/HPF (F) , >5 /HPF (M) • RBC >5 /HPF • RBC and WBC casts + • Albumin – Trace to +
  • 21. Urine C/S :- 1. >50,000 colonies of a single pathogen in suprapubic or catheter sample. 2. 10,000 colonies in the symptomatic child. 3. If the urinalysis result is positive, the patient is symptomatic, single organism with a colony count >100,000. 4. If any of these criteria are not met, confirmation of infection with a catheterized sample is recommended.
  • 22. Imaging studies 1.Radiological – MCU IVP X-ray KUB 2. Nuclear- USG DMSA scan - dimercaptosuccinic acid. DTPA scan - diethylene triamine pentacetate. MAG 3 scan- mercapto acetyl tri glycine.
  • 23. Renal scans • DMSA renal scan – anatomy of kidney (Scarring) • DTPA renal scan – Excretory function ,filtration function of kidney • MAG 3 with lasix renal scan – Sensitive quantitative information regarding kidney function and drainage , assesses the degree of blockage
  • 24.
  • 25. Principles of management 1. Treatment of acute infection 2. Prevention of further infection 3. Adequate investigation 4. Arrangement of further treatment 5. Follow up
  • 26. Choice & route of Treatment Usual indications for hospitalization for parenteral abx:- • Age <1 months • Clinical urosepsis or potential bacteremia • Immunocompromised patient • Complicated infection • Vomiting or inability to tolerate oral medication • Dehydrated • Lack of adequate outpatient follow-up • Failure to respond to outpatient therapy • Most infants older than one months with simple UTI can be safely managed as outpatients if follow-up is possible.
  • 27. • Empiric antimicrobial therapy be initiated while awaiting culture results. • If symptoms are mild and diagnosis is doubtful treatment can be awaited till c/s reports. • The ultimate choice of antimicrobial therapy is based upon the sensitivities of the urine culture isolate. • The duration of treatment:- Complicated UTI : 10-14days. Simple UTI : 7-10 days. • Asymptomatic bacteriuria does not require treatment except in pregnant.
  • 28. • Usually after 48-72 hrs, symptoms abate and oral intake improves and therapy is switched to an oral antibiotics. • Urine cultures should be repeated after 72 hours of therapy if the uropathogen is not susceptible to the antibiotic that is being used for treatment or if susceptibility testing is not performed. • Asymptomatic bacteriuria do not require treatment. • Routine alkalization of the urine is not necessary.
  • 29. • Parenteral antibiotics • Ceftriaxone 50-75mg/kg/day • Cefotaxime 100mg/kg/day • Inj Ampicillin (100mg/kg/day) + Inj. Gentamycin (3-5mg/kg/day) • Oral antibiotics • Cefixime 8-10mg/kg/day • Coamoxiclav 30-35mg/kg/day • Ciprofloxacin 10-20 mg/kg/day • Ofloxacin 15-20 mg/kg/day • Cephalexin 50-70mg/kg/day • Nitrofurantoin -1mg/kg/d • Co-trimoxazole-2mg/kg/d
  • 30. Prevention 1. General measures:- • Fluid intake • Complete and periodic voiding • Vioding at bed time • Perineal hyiene • Treatment of worms • Prevention of constipation • Avoid catheterization
  • 31. Prevention • Early treatment of congenital anomalies • Circumcision 2. Low dose chemoprophylaxis • UTI until radiological evaluation is complete. • Recurrent UTI (3 or more in a year). • VUR grade I- III • Post operative-PUJ,VUR grade IV & V, PUV • Chronic cystitis • Neurogenic bladder
  • 32. Prevention Commonly used drugs for prophylaxis:- • Co-trimoxazole-2mg/kg/d • Nalidixic acid-12.5mg/Kg/d • Nitrofurantoin -1mg/kg/d
  • 33. Follow up 1. Clinical- • During the year following infection • 1 year after starting prophylaxis • height, Blood pressure –recorded 2. Urine C/S- • 3 monthly-infancy • Fever & symptoms –older children 3. RFT 4. Imaging –when needed